It is possible that the adverse effect of obesity on pAMPK is mediated via adiponectin, the adipokine responsible for regulating glucose levels and fatty acid synthesis, which is decreased in obesity [19]. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.